Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-3-15
pubmed:abstractText
Angiogenesis inhibitors, such as TNP-470 and the nontoxic HPMA copolymer-TNP-470 (caplostatin), are emerging as a class of anticancer drugs. We report that TNP-470 and caplostatin inhibit vascular hyperpermeability of tumor blood vessels as well as that induced in mouse skin by different mediators. Treatment with TNP-470 or angiostatin for 3 days was sufficient to reduce permeability of tumor blood vessels, delayed-type hypersensitivity, and pulmonary edema induced by IL-2. TNP-470 also inhibited VPF/VEGF-induced phosphorylation of VEGFR-2, calcium influx, and RhoA activation in endothelial cells. These results identify an activity of TNP-470, that of inhibiting vessel hyperpermeability. This activity likely contributes to TNP-470's antiangiogenic effect and suggests that caplostatin can be used in the treatment of cancer and inflammation.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Angiostatins, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Cyclohexanes, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/O-(chloroacetylcarbamoyl)fumagillol, http://linkedlifedata.com/resource/pubmed/chemical/Sesquiterpenes, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor..., http://linkedlifedata.com/resource/pubmed/chemical/rhoA GTP-Binding Protein
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1535-6108
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
251-61
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15766663-Angiogenesis Inhibitors, pubmed-meshheading:15766663-Angiostatins, pubmed-meshheading:15766663-Animals, pubmed-meshheading:15766663-Calcium, pubmed-meshheading:15766663-Capillaries, pubmed-meshheading:15766663-Capillary Permeability, pubmed-meshheading:15766663-Cell Movement, pubmed-meshheading:15766663-Cyclohexanes, pubmed-meshheading:15766663-Endothelial Cells, pubmed-meshheading:15766663-Female, pubmed-meshheading:15766663-Hypersensitivity, Delayed, pubmed-meshheading:15766663-Interleukin-2, pubmed-meshheading:15766663-Male, pubmed-meshheading:15766663-Mice, pubmed-meshheading:15766663-Mice, Inbred C57BL, pubmed-meshheading:15766663-Mice, SCID, pubmed-meshheading:15766663-Mitogen-Activated Protein Kinases, pubmed-meshheading:15766663-Neoplasms, pubmed-meshheading:15766663-Pulmonary Edema, pubmed-meshheading:15766663-Sesquiterpenes, pubmed-meshheading:15766663-Skin, pubmed-meshheading:15766663-Vascular Endothelial Growth Factor A, pubmed-meshheading:15766663-Vascular Endothelial Growth Factor Receptor-2, pubmed-meshheading:15766663-rhoA GTP-Binding Protein
pubmed:year
2005
pubmed:articleTitle
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin.
pubmed:affiliation
Children's Hospital Boston and Harvard Medical School, Vascular Biology Program, Department of Surgery, 1 Blackfan Circle, Karp Family Research Laboratories, Floor 12, Boston, Massachusetts 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't